Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-16

Clinical Trial Update: Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of 0.12% chlorhexidine gluconate for peri-implant mucositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine gluconate 0.12% (chlorhexidine gluconate)

Snippet

Sponsor: Universidade Federal do Rio Grande do Norte | Conditions: Mucositis | Phase 2 | Status: COMPLETED